News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
GlaxoSmithKline Says Reports of Ireland Review Are “Completely Inaccurate”
June 10, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
in-Pharma Technologist -- GlaxoSmithKline (GSK) has described media reports of an overall review of operations in Ireland as “completely inaccurate”, telling in-PharmaTechnologist that the exercise only covers the plant in Cork.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Europe
GSK
MORE ON THIS TOPIC
Adcomms
Moderna’s once-rebuffed mRNA flu shot to face scrutiny from FDA adcomm
May 22, 2026
·
2 min read
·
Tristan Manalac
Insights
Inside Germany’s biotech capital infrastructure and innovation engine
May 21, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Regulatory
Pazdur declines to announce candidacy for vacated FDA commissioner role
May 20, 2026
·
4 min read
·
Heather McKenzie
FDA
FDA’s absent leaders, the millions pharma CEOs make, and pancreatic cancer’s momentum
May 20, 2026
·
1 min read
·
Jef Akst
